✦ LIBER ✦

Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer

✍ Scribed by Mazzoni, Francesca; Cecere, Fabiana Letizia; Meoni, Giulia; Giuliani, Costanza; Boni, Luca; Camerini, Andrea; Lucchesi, Sara; Martella, Francesca; Amoroso, Domenico; Lucherini, Elisa; Torricelli, Francesca; Di Costanzo, Francesco

Book ID: 121313759
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 598 KB
Volume: 82
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2013.08.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic significance of BRCA1, ERCC1,

Prognostic significance of BRCA1, ERCC1, RRM1, and RRM2 in patients with advanced non-small cell lung cancer receiving chemotherapy

✍ Zhao, Hui; Zhang, Huawei; Du, Yonghai; Gu, Xiaomeng 📂 Article 📅 2014 🏛 S. Karger AG 🌐 English ⚖ 681 KB

Randomized International Phase III Trial

Randomized International Phase III Trial of ERCC1 and RRM1 Expression-Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non-Small-Cell Lung Cancer

✍ Bepler, G.; Williams, C.; Schell, M. J.; Chen, W.; Zheng, Z.; Simon, G.; Gadgeel 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 184 KB

Phase II trial of S-1 as third-line or f

Phase II trial of S-1 as third-line or further chemotherapy in patients with advanced non-small-cell lung cancer

✍ Miyoshi, Seigo; Ito, Ryoji; Katayama, Hitoshi; Kadowaki, Toru; Yano, Shuichi; Wa 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 256 KB

Response to gemcitabine–platinum chemoth

Response to gemcitabine–platinum chemotherapy by single nucleotide polymorphisms of RRM1 and ERCC1 genes in patients with non-small-cell lung cancer

✍ In-Jae Oh; Hee-Jung Ban; Kyu-Sik Kim; Sang-Yun Song; Kook-Joo Na; Yun-Hyeon Kim; 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 163 KB

Phase II tailored S-1 regimen study of f

Phase II tailored S-1 regimen study of first-line chemotherapy in elderly patients with advanced and recurrent non-small cell lung cancer

✍ Takayuki Shiroyama, Takashi Kijima, Kiyoshi Komuta… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 305 KB

Gemcitabine and vinorelbine as first-lin

Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial

✍ E Laack; T Mende; J Benk; A Chemaissani; J Scholtze; C Lorenz; A Niestroy; K Dal 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 144 KB